MarketCapExport financials
MorphoSys AG (MOR)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
MorphoSys AG Income Statement 2023-2011 | MOR
Brief overview of revenue and earnings at MorphoSys AG
The figures are compared over a five-year interval. According to figures from MorphoSys AG, revenue changed from 76.4 million euros to 238 million euros over five years. Across the full period, sales moved by +211.7%; the average annual rate was 25.5%. The company expanded its revenue base at a high speed.
Gross profit changed from 74.6 million euros to 180 million euros (+141%). At the margin level, the figure shifted from 97.6% to 75.5%. The contraction points to pressure from direct costs or weaker pricing power.
EBITDA was −59.1 million euros at the beginning and 0 euros at the end of the period (+100%). Changes in revenue did not translate into comparable EBITDA performance. At the operating-margin level, the figure shifted from −77.3% to 0%. The company improved its ability to convert sales into EBITDA.
What the figures show
The results present an uneven picture without one dominant signal. The constructive conclusion rests on sales growth and positive operating leverage. The overall view is constrained by pressure from direct costs and limited operating profitability. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.
Annual Income Statement MorphoSys AG
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
624 M | 260 M | 315 M | 922 M | 1.13 B | 793 M | - | - | - | - | - | - | - |
Shares |
34.3 M | 34.2 M | 33.4 M | 32.5 M | 31.6 M | 31.3 M | 28.9 M | 26.4 M | - | - | - | - | - |
Historical Prices |
18.2 | 7.61 | 9.42 | 28.3 | 35.7 | 25.3 | - | - | - | - | - | - | - |
Net Income |
-190 M | -151 M | -514 M | 97.9 M | -103 M | -56.2 M | -69.8 M | -60.4 M | 14.9 M | -3.01 M | 13.3 M | 1.94 M | 8.22 M |
Revenue |
238 M | 278 M | 180 M | 328 M | 71.8 M | 76.4 M | 66.8 M | 49.7 M | 106 M | 64 M | 78 M | 51.9 M | 101 M |
Cost of Revenue |
58.4 M | 48.6 M | 32.2 M | 9.17 M | 12.1 M | 1.8 M | - | - | - | - | - | - | - |
Gross Profit |
180 M | 230 M | 147 M | 319 M | 59.7 M | - | - | 49.6 M | 106 M | 63.9 M | 77.9 M | 51.9 M | 93.8 M |
Operating Income |
-252 M | -221 M | -508 M | 18 M | -108 M | -59.1 M | -67.6 M | -59.9 M | - | - | - | - | - |
Interest Expense |
4.66 M | 2.75 M | 2.42 M | 1.02 M | 91 K | - | - | - | - | - | - | - | - |
EBITDA |
-252 M | -221 M | -508 M | 18 M | -108 M | -59.1 M | -67.6 M | -59.9 M | 13.9 M | -4.97 M | 12.1 M | 8.73 M | 18.8 M |
Operating Expenses |
432 M | 450 M | 656 M | 301 M | 168 M | 137 M | 134 M | 110 M | 93.4 M | 69.8 M | 68 M | 49.5 M | 81.6 M |
General and Administrative Expenses |
65.8 M | 60.1 M | 78.3 M | 51.4 M | 36.7 M | 21.9 M | 15.7 M | 13.4 M | 10.4 M | 9.61 M | 11.3 M | 12.1 M | 24.6 M |
Annual performance
Select metrics to display
All numbers in EUR currency
Quarterly Income Statement MorphoSys AG
| 2023-Q4 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
34.3 M | 34.2 M | - | - | - | 33.4 M | - | - | - | 32.5 M | - | - | - | 31.6 M | - | - | - | 31.3 M | - | - | - | 28.9 M | - | - | - | 26.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-190 M | -151 M | - | - | - | -514 M | - | - | - | 97.9 M | - | - | - | -103 M | - | - | - | -56.2 M | - | - | - | -69.8 M | - | - | - | -60.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
238 M | 278 M | - | - | - | 180 M | - | - | - | 328 M | - | - | - | 71.8 M | - | - | - | 76.4 M | - | - | - | 66.8 M | - | - | - | 49.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
58.4 M | 48.6 M | - | - | - | 32.2 M | - | - | - | 9.17 M | - | - | - | 12.1 M | - | - | - | 1.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
180 M | 230 M | - | - | - | 147 M | - | - | - | 319 M | - | - | - | 59.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-252 M | -221 M | - | - | - | -508 M | - | - | - | 18 M | - | - | - | -108 M | - | - | - | -59.1 M | - | - | - | -67.6 M | - | - | - | -59.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
4.66 M | 2.75 M | - | - | - | 2.42 M | - | - | - | 1.02 M | - | - | - | 91 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-252 M | -221 M | - | - | - | -508 M | - | - | - | 18 M | - | - | - | -108 M | - | - | - | -59.1 M | - | - | - | -67.6 M | - | - | - | -59.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
432 M | 450 M | - | - | - | 656 M | - | - | - | 301 M | - | - | - | 168 M | - | - | - | 137 M | - | - | - | 134 M | - | - | - | 110 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
65.8 M | 60.1 M | - | - | - | 78.3 M | - | - | - | 51.4 M | - | - | - | 36.7 M | - | - | - | 21.9 M | - | - | - | 15.7 M | - | - | - | 13.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in EUR currency
The income statement is one of the three key financial reports of a company MorphoSys AG (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
Schweiz
Canada
Germany
Niderland
China
Israel
